But now they’ve taken on the greatest challenge of all - death itself.
TIME has played host to several articles featuring ’longevity insiders’, and how they are determined to pull this off...
--- Google vs. Death By Harry McCracken; Lev Grossman | TIME
Larry Page, 40, is the co-founder and CEO of one of the most successful, ubiquitous and increasingly strange companies on the planet. Google is, of course, in the search business, and, more important for its profitability, it is in the online-advertising business. But it’s also in the driverless-car business, the wearable-computing business, and the business of providing Internet access to remote areas via high-altitude balloons, among countless others.
Page prefers to refer to the search giant’s more out-there ventures as moon shots. At the moment Google is preparing an especially uncertain and distant shot. It is planning to launch Calico, a new company that will focus on health and aging in particular. "In some industries," says Page, who spoke exclusively with TIME about the new venture, "it takes 10 or 20 years to go from an idea to something being real. Health care is certainly one of those areas. We should shoot for the things that are really, really important, so 10 or 20 years from now we have those things done."
The unavoidable question this raises is why a company built on finding information and serving ads next to it is spending untold amounts on a project that flies in the face of the basic fact of the human condition, the existential certainty of aging and death? To which the unavoidable answer is another question: Who the hell else is going to do it?
Google’s Calico: the War on Aging Has Truly Begun By Aubrey de Grey | TIME
Google’s Calico project means that hearts and minds have been convinced that we can defeat aging
To paraphrase Churchill’s words following the Second Battle of El Alamein: Google‘s announcement about their new venture to extend human life, Calico, is not the end, nor even the beginning of the end, but it is, perhaps, the end of the beginning.
Since the dawn of civilization, humanity has been enslaved by the knowledge that no lifestyle choice, no medicine, no quirk of fate can enable anyone to live for more than a few decades without suffering progressive, inexorable decline in physical and mental function, leading inevitably to death. So soul-destroying has this knowledge been, for almost everyone, that we have constructed our entire society and world view around ways to put it out of our minds, mostly by convincing ourselves that the tragedy of aging is actually a good thing. And why not? After all, why be preoccupied about something one cannot affect?
And yet, there have always been those few who aimed high: who were not cowed by this fear, but who instead found fulfilment in dedicating their lives to the crusade to bring aging under some kind of medical control. The earliest of those efforts may seem almost laughable to us today in their naivety, but that is the nature of the initial, exploratory phase of any pioneering technological quest.
The exploratory phase never ends cleanly, but rather by a series of fits and starts: leaps of faith that a judicious combination of tried and tested elements can deliver more than the sum of its parts. Often that faith is misplaced and the design fails, but that’s still progress: what is learned from the failure goes to inspire the next design, and success is eventually achieved. And so it will be with the development of medicine to maintain youth. As with any technological goal that is high on humanity’s priorities and is consistent with the laws of physics, it’s just a matter of time.
As little as 20 years ago, when I joined the pitifully small band of academics who call themselves biogerontologists, the prospects for defeating aging were so bleak that it was widely considered unscientific even to discuss it: according to the respectable view, our only option was to continue discovering more about the nature of aging until, by some miracle in the distant future, our body of knowledge took sufficient shape to reveal a route to intervention. A string of advances in the late 1990s, mostly made by researchers not focused on aging per se, changed that: it allowed, for the first time, the formulation of a realistic divide-and-conquer strategy against mankind’s most formidable foe. Many components of this strategy were at a dauntingly early stage of development, but all could be described in sufficient detail to offer hope for foreseeable success. As so often in science, many established luminaries voiced skepticism, and some still do; but the plan progressively attracted the support of world-leading experts in all the relevant disciplines, and as it has done so, funding —albeit far too little to maximise the rate of progress —has materialized too.
Now is the right time for a commercial entity to get heavily involved. One of the key activities of SENS Research Foundation, as a non-profit, is proof-of-concept research on key components of the anti-aging arsenal that are still too early-stage to constitute an attractive business proposition for all but the most visionary investors. But we’ve always made clear that our ultimate goal is to kick-start a real anti-aging industry: not the essentially cosmetic industry that goes by that name today, but a bona fide rejuvenation biotechnology industry, providing people with truly comprehensive restoration and preservation of youthful mental and physical function however long they live. And yes, one side-effect of this advance—a side-effect that we should all celebrate —is that most people will live a great deal longer than today, and will do so in the prime of health.
Starbucks Supports Pro-GMO Company 2014 11 26 Another reason why you should not go to Starbucks.
Starbucks has an image of being a socially responsible, environmentally friendly company (Really?). In 2013, 95 percent of their coffee was ethically sourced, and their goal is to reach 100 percent by 2015.1
Other goals include reducing water consumption by 25 percent in their company-operated stores by 20152 and mobilizing their employees and ...
Group Polarization and the Fad of Ethno-masochism 2014 11 26
From "Group polarization: A critical review and meta-analysis". Journal of Personality and Social Psychology. 6 50 (6): 1141--1151
The psychology of White self hatred. Political correctness IS a mental disorder.
Group polarization: A critical review and meta-analysis.
Isenberg, Daniel J. the paper
Harvard Professor Noel Ignatiev talks about how to end the White race
The History of Political Correctness
The Narrative: The origins of Political ...
Credo: A Nietzschean Testament by Jonathan Bowden 2014 11 26
This lecture by Jonathan Bowden was given at the 11th New Right meeting in London on September 8, 2007. The original title of the presentation was “The Art and Philosophy of Jonathan Bowden.”
I think ideas are inborn, and you’re attracted, if you have any, toward certain systems of thinking and sensibility and response. From a very young age, I was ...
A Look Back at the OJ Simpson Verdict -- Reactions 2014 11 26
This is a look back at the different reactions to the OJ Simpson verdict some 20 years ago (exact date of verdict was Oct 3, 1995). The OJ Simpson jury consisted of 9 Blacks, 1 Hispanic, and 2 Whites. It would raise eyebrows after they only deliberated for 4 hours in a case that they were involved in for almost ...
New York Times Publishes Darren Wilson’s Street Address and Photo of House #Ferguson 2014 11 26 Hey here are the two @nytimes scumbags that published Wilson’s home address. —> @juliebosman & @campbellnyt— Ben Howe (@BenHowe) November 25, 2014
Michael Brown’s Stepdad Shouting ‘Burn This Bitch Down’
The New York Times published information about the address of Ferguson Police Officer Darren Wilson on Monday in a move that has generated controversy. Tensions are running high in Ferguson, Missouri, as ...